Doctors have long sought conclusive confirmation when they suspect Parkinson’s. How long? More than 200 years! Finally, Amprion’s SYNTap™ Biomarker Test diagnoses Parkinson’s EARLY! Decades before symptoms.
What is the Parkinson's Test?
Named the SYNTap™ Biomarker Test, this diagnostic test tracks misfolded Synuclein, the biomarker driving Parkinson’s Disease (PD). By detecting PD on a molecular level, doctors can now diagnose the disease with confidence.
Who should take the Parkinson's Test?
These test benefits people who show:
- Early motor symptoms and/or movement disorders, which could indicate Parkinson’s.
- Prodromal signs of Parkinson’s, including loss of taste and/or smell or severe sleep disorders.
- Signs of a progressive autonomic disorder including fainting spells, heart rate irregularities, and bladder control loss.
What are the key benefits?
Parkinson’s biomarker testing offers remarkable benefits, such as the following:
- Enables accurate, early diagnosis so doctors can confidently prescribe proper treatment when patients are more responsive to drugs.
- Ends the misery of misdiagnosis, which leads to drug mistreatment causing more harm than help,
- Live a fuller, better quality of life through positive changes in diet, exercise, and sharing time with family and friends,
- Participate in the right clinical trials with confidence,
- Make life plans to navigate brain health journey, such as building a care team
- Enrich science to accelerate innovation and find cures for the next generations!
Molecular diagnosis is the crucial step to personalized medicine for treating Parkinson’s.
How the Parkinson's Test works
After a decade of strenuous development in our lab, it’s quite simple now. Here’re three key steps:
- Your doctor orders the test and submits a few drops of your cerebrospinal fluid (CSF),
- Our lab tests your sample for misfolded Synuclein,
- Your doctor receives the lab result within two weeks.
Click to see this simple process illustrated in an infographic.
Why use CSF instead of blood?
CSF testing offers the highest accuracy, reliability, and EARLY detection. Why?
Because if misfolded proteins are detectable in blood, that means they’ve breached the blood-brain barrier and are spreading throughout the body.
What does a negative test result mean?
A negative test result rules out Parkinson’s, even though the patient may show motor symptoms.
It is recommended that doctors continue monitoring their patient’s disease development by retaking the test in 12 -24 months as a routine check-up.
This biomarker test is an excellent way to monitor ongoing brain health.
The Significance of Biomarker Testing
Parkinson’s was first observed in 1817. We’ve been at war now fighting this disease for over 200 years.
To defeat the dark force, we need to travel beyond enemy lines to gather intel and formulate our battle plans.
Every biomarker test blasts a blazing light, illuminating the shadowy land of PD. With this ongoing reconnaissance, we’ll empower science to finally find a cure!
GET THE SYNTap™ BIOMARKER TEST
This diagnostic test identifies misfolded Synuclein, the biomarker driving Parkinson’s years before symptoms appear. Sign up to receive information about the test.